Cheryl Cohen Immunity Bio, Inc. (IBRX) insider trading activity

IBRX Quotes by TradingView

Cheryl Cohen is Director of ImmunityBio, Inc.. Currently has a direct ownership of 200,617 shares of IBRX, which is worth approximately $539,659. The most recent transaction as insider was on Aug 23, 2021, when has been sold 14,801 shares (Common Stock) at a price of $10.12 per share, resulting in proceeds of $149,786. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 201K
0% 3M change
0% 12M change
Total Value Held $539,659

Cheryl Cohen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 23 2021
SELL
Open market or private sale
$149,786 $10.12 p/Share
14,801 Reduced 6.87%
200,617 Common Stock
Aug 20 2021
SELL
Open market or private sale
$99,760 $10.0 p/Share
9,976 Reduced 4.43%
215,418 Common Stock
Aug 18 2021
SELL
Open market or private sale
$21,394 $10.03 p/Share
2,133 Reduced 0.94%
225,394 Common Stock
Aug 17 2021
SELL
Open market or private sale
$439,188 $10.12 p/Share
43,398 Reduced 16.02%
227,527 Common Stock

Also insider at

AADI
Aadi Bioscience, Inc. Healthcare
Director
MEIP
MEI Pharma, Inc. Healthcare
Director
CLDX
Celldex Therapeutics, Inc. Healthcare
CC

Cheryl Cohen

Director
San Diego, CA

Track Institutional and Insider Activities on IBRX

Follow ImmunityBio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IBRX shares.

Notify only if

Insider Trading

Get notified when an Immunity Bio, Inc. insider buys or sells IBRX shares.

Notify only if

News

Receive news related to ImmunityBio, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IBRX